Jae-Kwan Cha Selected Research

Jae-Kwan Cha Research Topics

Disease

61	Stroke (Strokes) 05/2024 - 10/2002
57	Ischemic Stroke 05/2024 - 10/2002
16	Atrial Fibrillation 04/2024 - 03/2014
12	Atherosclerosis 03/2024 - 01/2003
10	Infarction (Infarctions) 11/2021 - 01/2009
6	Embolic Stroke 11/2021 - 01/2010
4	Hemorrhagic Stroke 01/2023 - 01/2010
4	Thrombosis (Thrombus) 11/2021 - 10/2002
3	Myocardial Infarction 05/2024 - 01/2019
3	Hypertension (High Blood Pressure) 02/2023 - 01/2021
3	Cognitive Dysfunction 01/2023 - 05/2018
3	Transient Ischemic Attack 01/2022 - 01/2019
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 06/2019 - 09/2016
2	Hemorrhage 01/2023 - 01/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 12/2014
2	Cerebral Infarction 11/2021 - 06/2014
2	Pathologic Constriction (Stenosis) 11/2019 - 06/2008
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 11/2015 - 01/2003
2	Carotid Stenosis (Carotid Artery Stenosis) 06/2008 - 01/2003
1	Hyperglycemia 02/2023
1	Hypothermia 02/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Blood Vessel Dissection 01/2022
1	Neoplasms (Cancer) 01/2022
1	Headache (Headaches) 01/2022
1	Migraine Disorders (Migraine) 01/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 11/2021
1	Frailty 12/2020
1	Leukocytosis (Pleocytosis) 10/2020
1	Cerebral Hemorrhage 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 06/2017
1	Intracranial Embolism 01/2017
1	Constipation 01/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Myalgia 01/2017
1	Inflammation (Inflammations) 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Ischemia 07/2015
1	Diabetes Mellitus 12/2014

Drug/Important Bio-Agent (IBA)

16	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 10/2002
13	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2019 - 09/2010
10	Clopidogrel (Plavix)FDA Link 05/2024 - 10/2002
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 08/2004
8	AnticoagulantsIBA 04/2024 - 01/2018
6	Escitalopram FDA Link 11/2021 - 01/2017
6	P-SelectinIBA 12/2008 - 10/2002
5	LDL CholesterolIBA 11/2023 - 01/2016
5	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 12/2008
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 11/2019
4	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2016
4	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2014
3	oxidized low density lipoproteinIBA 09/2023 - 09/2022
3	LipidsIBA 09/2023 - 01/2016
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 12/2008
3	Adenosine Diphosphate (ADP)IBA 07/2016 - 06/2008
3	C-Reactive ProteinIBA 01/2016 - 10/2002
2	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 11/2021 - 01/2018
2	Probucol (Lorelco)FDA Link 01/2021 - 01/2020
2	Calcibiotic Root Canal SealerIBA 01/2021 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2016 - 10/2002
2	CholesterolIBA 11/2015 - 12/2014
1	Factor Xa (Coagulation Factor Xa)IBA 04/2024
1	edoxabanIBA 05/2023
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2023
1	oxiracetamIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2022
1	Antidepressive Agents (Antidepressants)IBA 11/2021
1	pro-brain natriuretic peptide (1-76)IBA 08/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	A-factor (Streptomyces)IBA 10/2020
1	Ezetimibe (Zetia)FDA Link 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Vitamin K FDA Link 01/2018
1	N(4)-oleylcytosine arabinosideIBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 10/2017
1	RivaroxabanIBA 10/2017
1	Air Pollutants (Pollutants, Air)IBA 01/2017
1	Particulate MatterIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	HDL LipoproteinsIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 11/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2015

Therapy/Procedure

26	Therapeutics 05/2024 - 08/2004
6	Thrombolytic Therapy 03/2018 - 01/2010
5	Thrombectomy 02/2023 - 01/2017
4	Secondary Prevention 05/2024 - 01/2022
2	Treatment Delay 11/2019 - 05/2016
2	Cerebral Revascularization 06/2018 - 10/2017
1	Ambulatory Care (Outpatient Care) 01/2021
1	Cardiopulmonary Resuscitation (CPR) 01/2016
1	Stents 05/2015